Literature DB >> 24112888

Deep brain stimulation for Parkinson's disease - patient selection.

Pierre Pollak1.   

Abstract

Proper selection of patients who will reliably benefit from deep brain stimulation (DBS) is critical to its success. This requires careful evaluation that should be delivered by an expert multidisciplinary team involving a movement disorder neurologist, a neurosurgeon, a neuropsychologist, and a psychiatrist. The most suitable candidates for DBS suffer from Parkinson's disease with motor fluctuations and/or dyskinesias that are not adequately controlled with optimized medical therapy, or with medication-refractory tremor. During the best on-motor periods, gait difficulties, instability, and speech problems should be minimal, reflecting an excellent response to levodopa in the ideal candidate. The cognitive, psychiatric, and behavioral status must be normal or minimally affected, with the exception of dopamine agonist drug-induced impulse control disorders, which are usually improved after successful surgery and drug withdrawal. Moreover, the patients have no serious comorbidities. Most patients corresponding to this profile suffer from a relatively young onset of Parkinson's disease, and are aged less than 70 years at the time of surgery. Indeed, most patients fall outside this ideal description, and the medical art is to appreciate for each patient the extent to which the alterations of these features can be accepted. Eventually, patients make their own decision from detailed information of their individualized risks and benefits of DBS. Patient expectations, cooperation, and familial support are also important considerations.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Parkinson’s disease; contraindications; deep brain stimulation; indications; predictive factors; surgical treatment

Mesh:

Year:  2013        PMID: 24112888     DOI: 10.1016/B978-0-444-53497-2.00009-7

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  15 in total

Review 1.  Preoperative Levodopa Response and Deep Brain Stimulation Effects on Motor Outcomes in Parkinson's Disease: A Systematic Review.

Authors:  Zhengyu Lin; Chencheng Zhang; Dianyou Li; Bomin Sun
Journal:  Mov Disord Clin Pract       Date:  2021-12-09

2.  Cognitive Impact of Deep Brain Stimulation in Parkinson's Disease Patients: A Systematic Review.

Authors:  Valentino Rački; Mario Hero; Gloria Rožmarić; Eliša Papić; Marina Raguž; Darko Chudy; Vladimira Vuletić
Journal:  Front Hum Neurosci       Date:  2022-05-13       Impact factor: 3.473

3.  Subcortical Iron Accumulation Pattern May Predict Neuropsychological Outcomes After Subthalamic Nucleus Deep Brain Stimulation: A Pilot Study.

Authors:  Gregory Brown; Guangwei Du; Elana Farace; Mechelle M Lewis; Paul J Eslinger; James McInerney; Lan Kong; Runze Li; Xuemei Huang; Sol De Jesus
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 4.  Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.

Authors:  Dhanya Vijayakumar; Joseph Jankovic
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

5.  Age modifies the risk factor profiles for acute kidney injury among recently diagnosed type 2 diabetic patients: a population-based study.

Authors:  Chia-Ter Chao; Jui Wang; Hon-Yen Wu; Jenq-Wen Huang; Kuo-Liong Chien
Journal:  Geroscience       Date:  2018-02-27       Impact factor: 7.713

6.  Optimizing the selection of Parkinson's disease patients for neuromodulation using the levodopa challenge test.

Authors:  Dinkar Kulshreshtha; Marcus Pieterman; Greydon Gilmore; Mandar Jog
Journal:  J Neurol       Date:  2021-06-30       Impact factor: 6.682

7.  Striatal Dopaminergic Innervation Regulates Subthalamic Beta-Oscillations and Cortical-Subcortical Coupling during Movements: Preliminary Evidence in Subjects with Parkinson's Disease.

Authors:  Andrea Canessa; Nicolò G Pozzi; Gabriele Arnulfo; Joachim Brumberg; Martin M Reich; Gianni Pezzoli; Maria F Ghilardi; Cordula Matthies; Frank Steigerwald; Jens Volkmann; Ioannis U Isaias
Journal:  Front Hum Neurosci       Date:  2016-12-06       Impact factor: 3.169

8.  Impact of Combined Subthalamic Nucleus and Substantia Nigra Stimulation on Neuropsychiatric Symptoms in Parkinson's Disease Patients.

Authors:  U Hidding; A Gulberti; A Horn; C Buhmann; W Hamel; J A Koeppen; M Westphal; A K Engel; C Gerloff; D Weiss; C K E Moll; M Pötter-Nerger
Journal:  Parkinsons Dis       Date:  2017-01-26

9.  Impaired reach-to-grasp kinematics in parkinsonian patients relates to dopamine-dependent, subthalamic beta bursts.

Authors:  Matteo Vissani; Chiara Palmisano; Jens Volkmann; Gianni Pezzoli; Silvestro Micera; Ioannis U Isaias; Alberto Mazzoni
Journal:  NPJ Parkinsons Dis       Date:  2021-06-29

10.  Early versus Late Application of Subthalamic deep brain Stimulation to Parkinson's disease patients with motor complications (ELASS): protocol of a multicentre, prospective and observational study.

Authors:  Lulu Jiang; Wai Sang Poon; Elena Moro; Wenbiao Xian; Chao Yang; Xian Lun Zhu; Jing Gu; Xiaodong Cai; Jinlong Liu; Vincent Mok; Yanmei Liu; Shaohua Xu; Qiyu Guo; Wanru Chen; Ling Chen
Journal:  BMJ Open       Date:  2017-11-16       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.